VBS — Vectus Biosystems Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- AU$3.94m
- AU$3.89m
- AU$0.02m
Annual income statement for Vectus Biosystems, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
R2021 June 30th | 2022 June 30th | R2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0.056 | 0.077 | 0.019 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 3.75 | 4.6 | 4.59 | 3.47 | 2.18 |
| Operating Profit | -3.75 | -4.6 | -4.54 | -3.39 | -2.16 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -3.86 | -3.99 | -3.44 | -2.34 | -1.78 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -3.86 | -3.99 | -3.44 | -2.34 | -1.78 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -3.86 | -3.99 | -3.44 | -2.34 | -1.78 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -3.86 | -3.99 | -3.44 | -2.34 | -1.78 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.139 | -0.12 | -0.072 | -0.044 | -0.032 |